Precision Radiation Oncology (PRO, which is also called BLUE JOURNAL) aims to offer a forum for collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and clinical research in radiation oncology. The editors encourage contributions relevant to radiodiagnosis, radiotherapy, radiation physics, radiation biology, interventional therapy, and nuclear medicine in cancer, including basic cancer research, as well as translational and clinical cancer research. Precision Radiation Oncology is supported by Sino-American Network for Therapeutic Radiology and Oncology(SANTRO), and Chinese Anti-Cancer Association(CA-CA) .

Precision Radiation Oncology is an open access journal. Manuscripts accepted for publication will be published as open access articles, immediately free to read, download and share. Authors or their funder will be not required to pay an article publication charge at present.

The journal publishes a range of article types including: Original articles, Clinical Guidelines, Consensus, Commentaries, Editorials, Reviews, Meeting reports, Case reports, Brief Reports, Research letters, Letters to the Editor, and Perspective.